In Brief This Week: Qiagen; Atossa Genetics; Genomic Vision; In Silico Medicine; NextGxDx; AITbiotech; InterSystems; Intrexon | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen disclosed in its 2013 annual report filed with the US Securities and Exchange Commission that it acquired CLC Bio for $68.2 million, net of cash acquired. It added in the document that the deal was "not significant" to its overall consolidated financial statements. Qiagen announced the acquisition in October but had not disclosed the financial terms at that time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.